Navigation Links
Dendreon to Hold Conference Call on Tuesday, August 11, 2009 at 11:30 AM ET
Date:7/30/2009

SEATTLE, July 30 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) management will host a conference call on Tuesday, August 11, 2009 at 8:30 a.m. PT; 11:30 a.m. ET to review second quarter 2009 financial results. Access to the discussion may be obtained as follows:

    Time:      11:30 AM ET /8:30 AM PT
    Date:      August 11, 2009
    Dial-in:   1-877-548-7903 (domestic) or +1-719-325-4873 (international)
    Webcast:   www.dendreon.com (homepage and investor relations section)

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-888-203-1112 or +1-719-457-0820 for international callers; the conference ID number is 3674422. The replay will be available from 2:30 pm ET on Tuesday, August 11 until 11:59 pm ET on Thursday, August 13. In addition the webcast will be archived for on-demand listening for 30 days at www.dendreon.com.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets TRPM8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit www.dendreon.com.

'/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
2. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
3. Dendreon Announces Closing of Common Stock Offering
4. Dendreon Announces Common Stock Offering
5. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
6. Dendreon Reports First Quarter 2009 Financial Results
7. Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
8. Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
9. Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
10. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
11. Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... electricity, to move data would consume much less ... concern as chips, transistor counts rise. , Of ... light emitters, modulators, and detectors emitters are ... for optical chips is molybdenum disulfide (MoS2), which ... single, atom-thick layer. Other experimental on-chip light emitters ...
(Date:9/19/2014)... Sept. 19, 2014  Nektar Therapeutics (NASDAQ: ... studies characterizing the analgesic profiles of a series ... receptor agonist molecules. The preclinical research candidates were ... platform. The analgesic properties of kappa ... literature. 1,2 Kappa opioid receptors are expressed ...
(Date:9/19/2014)... 19, 2014 Cereal grain scientists, ... will gather October 5–8, 2014, for the AACC ... Convention Center in Providence, Rhode Island. The comprehensive ... of food scientists, chemists, microbiologists, nutritionists, and those ... production management. To date, 1,000 attendees have registered ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Bipartisan passage ... a bill designed to stimulate development and commercialization of ... being praised by leaders of SPIE, the international ... Revitalizing American Manufacturing and Innovation (RAMI) Act, now moves ... authors have said they are optimistic that it will ...
Breaking Biology Technology:Toward optical chips 2Toward optical chips 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 2Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 3Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 4Nektar Presents Positive Preclinical Data on Oral, Peripherally-Acting Kappa Agonist Molecules at 2014 American Academy of Pain Management Meeting 5Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 2Latest Research on Cereal Grain Quality, Health Benefits and Food Production to be Presented During the AACC International Annual Meeting 3House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3
... , , , ... 8 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) today ... bavituximab in combination with carboplatin and paclitaxel in advanced breast cancer ... enrolled and patients are currently undergoing treatment and follow-up. The ...
... , , ATLANTA and BRIDGEWATER, N.J. ... pollen, as parents prepare for this year,s back to school they should ... nasal allergies ease into the new school year, the My Xperts(TM) program, ... a team of indoor and outdoor nasal allergy experts to help parents ...
... , NOVATO, Calif., Sept. 8 BioMarin Pharmaceutical Inc. (Nasdaq: ... of BioMarin, will present a company update at the Morgan Stanley Healthcare ... p.m. ET. , , Interested parties may ... section of the BioMarin website, www.BMRN.com . A ...
Cached Biology Technology:Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 2Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 3Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 4Peregrine Pharmaceuticals Reports Advances in Bavituximab Clinical Program 5VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 2VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 3VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 4VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 5VIDEO: Nasal Allergy Experts Offer Free Advice for Back to School Sneezin' 6BioMarin to Present at the Morgan Stanley Healthcare Conference 2
(Date:9/19/2014)... years has adapted to the arctic cold, and then you ... for you. , This is happening to the small white ... called nonylphenol, comes from the use of certain detergents, pesticides ... disruptor, but when entering the worm it has another dangerous ... in its body from cold damage. , Enchytraeus albidus ...
(Date:9/18/2014)... GSA Bulletin study uses tree rings to document ... Wash in northern New Mexico, USA. By determining burial ... investigators were able to precisely date arroyo sedimentary beds ... data with aerial imagery, LiDAR, longitudinal profiles, and repeat ... Arroyos are deep, oversized channels that have vertical or ...
(Date:9/18/2014)... A novel robotic system that can operate inside the ... as part of a biomedical research partnership program at ... of determining if the robot, in conjunction with real-time ... accurate, less costly, and less discomforting for the patient. ... prostate cancer therapies with greater precision. , Developed by ...
Breaking Biology News(10 mins):Environmental pollutants make worms susceptible to cold 2Environmental pollutants make worms susceptible to cold 3Tree rings and arroyos 2Tree rings and arroyos 3Tree rings and arroyos 4Tree rings and arroyos 5Tree rings and arroyos 6Tree rings and arroyos 7Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 2Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 3Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 4Trial begins for MRI-compatible robot designed to improve accuracy of prostate biopsies 5
... MARC (Minority Access to Research Careers) Program has ... Annual International Conference on Intelligent Systems for Molecular ... on Computational Biology (ECCB), an official conference of ... Vienna, Austria from July 15-19, 2011. These ...
... (CHICAGO) Women with the BRCA1 or BRCA2 gene ... of breast and ovarian cancer, can safely take hormone-replacement ... of their ovaries, according to new research from the ... which will be presented Monday, June 6 during the ...
... Event details: , 4:00 5:00 PM eastern, Monday, June ... The Gulf of Mexico is vital to the United States ... recreational fishery production, shipping, and tourism. Its cultural significance ... inhabitants in the face of disasters has inspired the rest ...
Cached Biology News:Women with BRCA mutations can take hormone-replacement therapy safely after ovary removal 2Women with BRCA mutations can take hormone-replacement therapy safely after ovary removal 3Gulf of Mexico ecosystems 1 year after the Deepwater Horizon 2Gulf of Mexico ecosystems 1 year after the Deepwater Horizon 3
... of a class of proteins who function to ... S plays an integral role in proofreading the ... excision repair and in preventing chromosomal recombination between ... DNA specifically at base pair mismatches and small ...
TGase3 (S-20)...
... the industrys first PCI Express image acquisition ... acquire images at the highest speeds, resolutions, ... cameras to perform demanding imaging applications such ... analysis, and advanced motion tracking. In ...
Simple operation and an easy-to-read LCD display characterize our Classic Light balances. * Taring range 0...1510 g...
Biology Products: